Both the House and Senate are intent on increasing the US Food and Drug Administration (FDA) budget for next year, but the figure is likely to be far short of the $6.5bn initially requested by president Joe Biden
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.